HIV-Related Oral Lesions, Demographic Factors, Clinical Staging and Anti-Retroviral Use

Archives of Medical Research

Volumn 37, Issue 5, 2006, Pages 646-654

  Ramírez Amador, Velia ^a   Anaya Saavedra, Gabriela ^a   Calva, Juan J ^b   Clemades Pérez de Corcho, Tirso ^c   López Martínez, Carlos ^c   González Ramírez, Imelda ^a   Sierra Madero, Juan ^b  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^c Clínica Especializada Condesa   (Mexico)

Author keywords

Hairy leukoplakia; HIV; Oral candidiasis; Oral lesions; Risk factors

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HEALTH CENTER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LABORATORY TEST; LEUKOPLAKIA; LOGISTIC REGRESSION ANALYSIS; MALE; MEXICO; MORBIDITY; MOUTH EXAMINATION; MOUTH LESION; OBSERVATIONAL STUDY; PERIODONTAL DISEASE; PREVALENCE;

ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LEUKOPLAKIA, HAIRY; MALE; MEXICO; PERIODONTAL DISEASES; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, KAPOSI; SOCIOECONOMIC FACTORS;

EID: 33646859955     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.01.002     Document Type: Article

References (55)

1. Kaplan J.E., Hanson D., Dworkin M.S., Frederick T., Bertolli J., Lindegren M.L., et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30 (2000) 5-14
2. Hung C.C., and Chang S.C. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections. J Antimicrob Chemother 54 (2004) 849-853
3. Mocroft A., Kirk O., Clumeck N., Gargalianos-Kakolyris P., Trocha H., Chentsova N., et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study. Cancer 100 (2004) 2644-2654
4. Patton L.L., McKaig R., Strauss R., Rogers D., and Eron Jr. J.J. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 89 (2000) 299-304
5. Tappuni A.R., and Fleming G.J. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 92 (2001) 623-628
6. Ramírez-Amador V., Esquivel-Pedraza L., Sierra-Madero J., Anaya-Saavedra G., González-Ramírez I., and Ponce-de-León S. The changing clinical spectrum of human immunodeficiency virus (HIV)-related oral lesions in 1,000 consecutive patients. A 12-year study in a referral center in Mexico. Medicine 82 (2003) 39-50
7. Eyeson J.D., Tenant-Flowers M., Cooper D.J., Johnson N.W., and Warnakulasuriya K.A.A.S. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. J Oral Pathol Med 31 (2002) 169-174
8. Nicolatou-Galitis O., Velegraki A., Paikos S., Economopoulou P., Stefaniotis T., Papanikolaou I.S., et al. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study. Oral Dis 10 (2004) 145-150
9. Schmidt-Westhausen A.M., Priepke F., Bergmann F.J., and Reichart P.A. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 29 (2000) 336-341
10. Coogan M.M., Greenspan J., and Challacombe S.J. Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ 83 (2005) 700-706
11. Greenspan D., Canchola A.J., MacPhail L.A., Cheikh B., and Greenspan J.S. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 357 (2001) 1411-1412
12. Kamiru H.N., and Naidoo S. Oral HIV lesions and oral health behaviour of HIV-positive patients atttending the Queen Elizabeth II Hospital, Maseru, Lesotho. SADJ 57 (2002) 479-482
13. Bendick C., Scheifele C., and Reichart P.A. Oral manifestations in 101 Cambodian patients with HIV infection and AIDS. J Oral Pathol Med 31 (2002) 1-4
14. Holmes H.K., and Stephen L.X.G. Oral lesions of HIV infection in developing countries. Oral Dis 8 (2002) 40-43
15. International Labour Office. The Revised International Standard Classification of Occupation (ISCO-88). Geneva (1990)
16. Centers for Disease Control and Prevention. 1993 Revised Classification System for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (1992) 1-19
17. Yeni P.G., Hammer S.M., Carpenter C.C.J., Cooper D.A., Fischl M.A., Gatell J.M., et al. Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel. JAMA 288 (2002) 222-235
18. EC-Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 22 (1993) 289-291
19. th, 2005.
20. th, 2005.
21. th Conference on Retroviruses and Opportunistic Infections. Boston: February 2005.
22. Greenwood I., Zakrzewska J.M., and Robinson P.G. Changes in the prevalence of HIV-associated mucosal disease at a dedicated clinic over 7 years. Oral Dis 8 (2002) 90-94
23. + cell count and viral load in an Italian study population. J Oral Pathol Med 28 (1999) 173-177
24. Patton L.L., Phelan J.A., Ramos-Gomez F.J., Nittayananta W., Shiboski C.H., and Mbuguye T.L. Prevalence and classification of HIV-associated oral lesions. Oral Dis 8 (2002) 98-109
25. Pinheiro A., Marcenes W., Zakrzewska J.M., and Robinson P.G. Dental and oral lesions in HIV infected patients: a study in Brazil. Int Dent J 54 (2004) 131-137
26. Chattopadhyay A., Caplan D.J., Slade G.D., Shugars D.C., Tien H.-C., and Patton L.L. Risk indicators for oral candidiasis and oral hairy leukoplakia in HIV-infected adults. Community Dent Oral Epidemiol 33 (2005) 35-44
27. Patton L.L., McKaig R., Strauss R., and Eron J.J. Oral manifestations of HIV in a southeast USA population. Oral Dis 4 (1998) 164-169
28. Campo J., Del Romero J., Castilla J., García S., Rodríguez C., and Bascones A. Oral candidiasis as a clinical marker related to viral load, CD4 lymphocyte count and CD4 lymphocyte percentage in HIV-infected patients. J Oral Pathol Med 31 (2002) 5-10
29. Kerdpon D., Pongsiriwet S., Pangsomboon K., Iamaroon A., Kampoo K., Sretrirutchai S., et al. Oral manifestations of HIV infection in relation to clinical and CD4 immunological status in northern and southern Thai patients. Oral Dis 10 (2004) 138-144
30. Chattopadhyay A., Caplan D.J., Slade G.D., Shugars D.C., Tien H.-C., and Patton L.L. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in North Carolina. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99 (2005) 39-47
31. Ramírez-Amador V., Ponce-De-León S., Sierra-Madero J., Soto-Ramírez L., Esquivel-Pedraza L., and Anaya-Saavedra G. Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients. AIDS Res Hum Retrov 21 (2005) 981-990
32. Arribas J.R., Hernández-Albujar S., González-García J.J., Peña J.M., Gonzalez A., Canedo T., et al. Impact of protease inhibitor therapy on HIV-related oropharyngeal candidiasis. AIDS 14 (2000) 979-985
33. Diz Dios P., Ocampo A., Miralles C., Limeres J., and Tomás I. Changing prevalence of human immunodeficiency virus-associated oral lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 403-404
34. Cassone A., Tacconelli E., De Bernardis F., Tumbarello M., Torosantucci A., Chiani P., et al. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis 185 (2002) 188-195
35. Greenspan D., Gange S.J., Phelan J.A., Navazesh M., Alves M.E., MacPhail L.A., et al. Incidence of oral lesions in HIV-1-infected women: reduction with HAART. J Dent Res 83 (2004) 145-150
36. Ammatuna P., Campisi G., Giovannelli L., Giambelluca D., Alamo C., Mancuso S., et al. Presence of Epstein-Barr Virus, cytomegalovirus and human papillomavirus in normal oral mucosa of HIV-infected and renal transplant patients. Oral Dis 7 (2001) 34-40
37. Crawford D.H., Swerdlow A.J., Higgins C., McAulay K., Harrison N., Williams H., et al. Sexual history and Epstein-Barr virus infection. J Infect Dis 186 (2002) 731-736
38. Van Baarle D., Hovenkamp E., Dukers N.H.T.M., Renwick N., Kersten M.L., Goudsmit J., et al. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 181 (2000) 2045-2209
39. Shiboski C.H., Neuhaus J.M., Greenspan D., and Greenspan J.S. Effect of receptive oral sex and smoking on the incidence of hairy leukoplakia in HIV-positive gay men. J Acquired Immune Defic Syndr 21 (1999) 236-242
40. Ramírez-Amador V., Esquivel-Pedraza L., Sierra-Madero J., Ponce de León S.E., and Ponce de León S.E. Oral manifestations of HIV infection by gender and transmission category in Mexico City. J Oral Pathol Med 27 (1998) 135-140
41. De Faria P.R., Vargas P.A., Saldiva P.H.N., Böhm G.M., Mauad T., and de Almeida O.P. Tongue disease in advanced AIDS. Oral Dis 11 (2005) 72-80
42. Palacio H., Hilton J.F., Canchola A.J., and Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol 14 (1997) 338-342
43. Greenspan D., Komaroff E., Redford M., Phelan J.A., Navazesh M., Alves M.E., et al. Oral mucosal lesions and HIV viral load in the women's interagency HIV study (WIHS). J Acquir Immune Defic Syndr 25 (2000) 44-450
44. Cannon M.J., Dollard S.C., Black J.B., Edlin B.R., Hannah C., Hogan S.E., et al. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 17 (2003) 215-222
45. Haramati L.B., and Wong J. Intrathoracic Kaposi's sarcoma in women with AIDS. Chest 117 (2000) 410-414
46. Chidzonga M.M. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 9 (2003) 317-322
47. Olweny C.L.M., Borok M., Gudza I., Clinch J., Cheang M., Kiire C.F., et al. Treatment of AIDS-associated Kaposi's sarcoma in Zimbabwe: results of a randomized quality of life focused clinical trial. Int J Cancer 113 (2005) 632-639
48. Nawar E., Mbulaiteye S.M., Gallant J.E., Wohl D.A., Ardini M., Hendershot T., et al. Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS. Int J Cancer 115 (2005) 296-300
49. Dukers N.H.T.M., Renwick N., Prins M., Geskus R.B., Schulz T.F., Weverling G.J., et al. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am J Epidemiol 151 (2000) 213-224
50. Levine A.M., and Tulpule A. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer 37 (2001) 1288-1295
51. Jacobson L.P., Yamashita T.E., Detels R., Margolick J.B., Chmiel J.S., Kingsley L.A., et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 21 (1999) 34-41
52. Portsmouth S., Stebbing J., Gill J., Mandalia S., Bower M., Nelson M., et al. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma. AIDS 17 (2003) 17-22
53. Kroidl A., Schaeben A., Oette M., Wettstein M., Herfordt A., and Haussinger D. Prevalence of oral lesions and periodontal diseases in HIV-infected patients on antiretroviral therapy. Eur J Med Res 10 (2005) 448-453
54. Glick M., Muzyka B.C., Salkin L.M., and Lurie D. Necrotizing ulcerative periodontitis: a marker for immune deterioration and a predictor for the diagnosis of AIDS. J Periodontol 65 (1994) 393-397
55. Lamster I.B., Grbic J.T., Mitchell-Lewis D.A., Begg M.D., and Mitchell A. New concepts regarding the pathogenesis of periodontal disease in HIV infection. Ann Periodontol 3 (1998) 62-75